TOPALOGLU, H. Expensive molecular therapies for rare genetic disorders: carrier detection or newborn screening should be the strategy. A personal opinion. Journal of the International Child Neurology Association, [S. l.], v. 1, n. 1, 2021. DOI: 10.17724/jicna.2021.225. Disponível em: https://jicna.org/index.php/journal/article/view/225. Acesso em: 22 may. 2022.